| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xu,Yu-Dong | Chairman | 2.26% | |
| Jian,Xue-Ren | Director | 0.00% | |
| Zhou,Zhi-Cheng | Director | 0.00% | |
| Jonathan Ross | Independent Director | 0.00% | |
| Huang,Qiu-Yong | Independent Director | 0.00% | |
| Wang,He-Wei | Independent Director | 0.00% | |
| Xu,Jian-Hua | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 335,313 | 1,507,390 | 1,852,883 |
| Operating cost | 189,177 | 927,137 | 1,213,028 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 146,136 | 580,253 | 639,855 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 146,136 | 580,253 | 639,855 |
| Operating expenses | 131,557 | 573,075 | 541,149 |
| Other gain (loss), net | 0 | -4,512 | -312 |
| Operating profit (loss) | 14,579 | 2,666 | 98,394 |
| Non-operating income and expenses | 9,086 | 61,580 | 16,591 |
| Net profit (loss) before tax | 23,665 | 64,246 | 114,985 |
| Income tax expense (benefits) | 3,201 | 14,175 | 14,797 |
| Net profit (loss) of ongoing business for the current period | 20,464 | 50,071 | 100,188 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 20,464 | 50,071 | 100,188 |
| Other comprehensive profit (loss), net | 8,740 | 32,883 | 5,077 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 29,204 | 82,954 | 105,265 |
| Net profit (loss) attributable to owners of parent company | 26,362 | 87,023 | 84,169 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -5,898 | -36,952 | 16,019 |
| Comprehensive profit (loss) attributable to owners of parent company | 35,102 | 119,906 | 89,246 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -5,898 | -36,952 | 16,019 |
| Basic earnings per share (yuan) | 0 | 1 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 44,290 | 322,690 | 387,651 |
| Net cash inflows (outflows) from investing activities | -534,120 | -106,477 | -124,950 |
| Net cash inflow (outflow) from financing activities | 257,915 | 515,709 | -608,827 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 807 | 9,035 | -4,135 |
| Increase (decrease) in cash and cash equivalents in the current period | -231,108 | 740,957 | -350,261 |
| Beginning balance of cash and cash equivalents | 1,331,043 | 590,086 | 940,347 |
| Ending balance of cash and cash equivalents | 1,099,935 | 1,331,043 | 590,086 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 2,385,776 | 2,440,523 | 2,014,439 |
| Non-current asset | 1,768,392 | 1,415,604 | 1,349,144 |
| Total asset | 4,154,168 | 3,856,127 | 3,363,583 |
| Current liability | 368,683 | 417,274 | 824,409 |
| Non-current liability | 1,156,914 | 841,760 | 147,810 |
| Total liability | 1,525,597 | 1,259,034 | 972,219 |
| share capital | 752,143 | 752,370 | 750,740 |
| Equity - secruity token | - | - | - |
| capital reserve | 404,756 | 403,797 | 356,529 |
| retained earning | 1,335,241 | 1,306,196 | 1,274,154 |
| Other equity | 24,808 | 20,063 | -16,156 |
| Treasury stock | -3,544 | -3,544 | -3,544 |
| Total equity attributable to owners of parent company | 2,513,404 | 2,478,882 | 2,361,723 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 115,167 | 118,211 | 29,641 |
| Total Equity | 2,628,571 | 2,597,093 | 2,391,364 |
| Share capital awaiting retirement (unit: share) | - | - | 0 |
| Issued shares of advance equity (unit: shares) | 14,000 | 58,250 | 6,150 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 124,000 | 124,000 | 124,000 |
| Net asset value per share | 33 | 33 | 31 |
